Skip to main content

Boston Scientific Corp(BSX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low61.78
Day High65.32
Open:62.51
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
Futures-options traders work on the floor at the New York Stock Exchange's NYSE American (AMEX) in New York City, U.S., April 13, 2026. REUTERS/Brendan McDermid
the globe and mail

Market Factors: ‘Perfect’ stocks to hold for current geopolitical chaos

Plus, why oil price increases are less dangerous to the economy
Motley Fool
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations
Motley Fool
BSX Q2 2025 Earnings Transcript
StockStory
Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales
BSX
StockStory
Boston Scientific (BSX) Q1 Earnings: What To Expect
BSX
Tipranks
Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative
Tipranks
Boston Scientific’s RESPI Study Signals Quiet Push Into Smart Respiratory Monitoring
StockStory
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
STKL
Tipranks
Analysts’ Top Healthcare Picks: Boston Scientific (BSX), Alto Neuroscience, Inc. (ANRO)
Stock Target Advisor
Stocks Dive Again on Oil as German Inflation Spikes-Market Analysis for March 30th, 2026
add stock symbols: "3M Co: Jefferies lowered its price target to $160 from $180, citing a weaker macro backdrop and increased demand volatility from tariffs. Bank of America Corp: The ba
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Roivant Sciences (ROIV), Boston Scientific (BSX)
Tipranks
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Boston Scientific (BSX)
StockStory
3 of Wall Street’s Favorite Stocks for Long-Term Investors
LDOS
Tipranks
Boston Scientific (BSX) Receives a Buy from RBC Capital
Tipranks
Boston Scientific (BSX) Gets a Hold from Erste Group
Tipranks
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Alto Neuroscience, Inc. (ANRO)
Zacks Investment Research
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
Tipranks
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT)
Tipranks
Boston Scientific (BSX) Gets a Buy from Canaccord Genuity
Tipranks
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX)
StockStory
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast
CAR
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Alumis Inc. (ALMS) and Boston Scientific (BSX)
Tipranks
Boston Scientific (BSX) Receives a Buy from RBC Capital
Tipranks
Boston Scientific Reports Strong HI-PEITHO Trial Results for EKOS
Tipranks
Barclays Sticks to Its Buy Rating for Boston Scientific (BSX)
Motley Fool
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
StockStory
Boston Scientific (BSX) Stock Trades Down, Here Is Why
BSX
Tipranks
Boston Scientific (BSX) Gets a Buy from RBC Capital
Tipranks
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Climb Bio (CLYM) and Boston Scientific (BSX)
MarketBeat
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
MarketBeat.com
Tipranks
Jefferies Remains a Buy on Boston Scientific (BSX)

Profile

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.